The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Modern Water Q2 orders exceed £3m, RPT

30 Jun 2022 07:00

RNS Number : 7307Q
Deepverge PLC
30 June 2022
 

30 June 2022

 

DeepVerge PLC

 

("DeepVerge" or "the Company" or "the Group")

 

Modern Water Q2 orders exceed £3m post COVID restrictions in China & South Asia

New monitoring and membrane revenues secured in high value microchip fabrication sector

 

DeepVerge plc (AIM: DVRG), is pleased to announce that Modern Water has secured Q2 orders in excess of £3m in China and South Asia for delivery during the current financial year. Significant sales of water monitoring and membrane water recovery have been secured with Tier 1 partners. This includes a new vertical in the technology sector, specifically microchip fabrication manufacturers, opening up a very large new vertical worldwide market for the Modern Water division.

 

The Modern Water sales teams in US, the EU, China and South Asia have put strategies in place to diversify which has led to the opening up of new verticals and growth in new markets. This focus has resulted in a number of significant seven figure deals across the markets of South Asia and the Middle East.

Gerard Brandon CEO DeepVerge plc, commented:

"Chinese and South Asian markets have been challenging because our staff, customer staff, partner staff and staff of collaborators that we're in negotiation with, have been rolling in and out of lockdowns for the best part of two years. Whilst we have continued to generate business, communication between teams, as well as supply chains, has been challenging. However through our drive to build the business and the intensity of our marketing and selling strategy, mostly online, we are now seeing a rebound as a result of pent up demand which is putting the market back on track.

We changed the business model in Modern Water from selling lower ticket equipment to medium and large enterprise solution sales. Investment was targeted to upgrading existing Microtox and Microtrace equipment, adding more efficient data aggregation capabilities, interfacing with third party systems and integrating with large SCADA operational management systems. Sales focus has been to identify partners capable of making larger solution sales and training their staff to sell our new offering. This strategy is now gaining traction and we continue to build our presence as a world leading water testing solutions provider."

 

Related party transaction

DeepVerge's subsidiary, Innovenn UK Limited, has signed a second Statement of Work ("Further Order") with Microsaic Systems plc ("Microsaic") under the previously announced Manufacturing Services Framework Agreement ("MFSA") between the same parties. This contract has a value of approximately £600,000 and constitutes a related party transaction for DeepVerge under Rule 13 of the AIM Rules for Companies, by virtue of its size and Microsaic and DeepVerge having two directors in common.

 

At the time of entering into the MFSA, the independent directors (being all the directors of DeepVerge save for Gerard Brandon and Nigel Burton who are also directors of Microsaic) considered, having consulted with the Company's nominated adviser, that the terms of the MFSA and an initial order under its terms were fair and reasonable insofar as the Company's shareholders are concerned. The independent directors also consider that the terms of the Further Order are consistent with the terms of both the MSFA and the initial order thereunder, and therefore considers the terms of the Further Order to be fair and reasonable insofar as shareholders are concerned.

 

DeepVerge plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin

 

About Modern Wate(www.modernwater.com)

Modern Water is the environmental division of DeepVerge that has developed and commercialised cutting-edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation. The division offers an automated real-time contamination detection range of equipment, including Microtox® PD, for the identification of SARS-CoV-2 hotspots and other pathogens in wastewater.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKAURUSUNUUR
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.